Published in J Virol on November 01, 1996
Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev (2002) 2.86
Vaccination with DNA encoding the immunodominant LACK parasite antigen confers protective immunity to mice infected with Leishmania major. J Exp Med (1997) 2.81
Interferon gamma regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med (1998) 2.04
Two antigenic peptides from genes m123 and m164 of murine cytomegalovirus quantitatively dominate CD8 T-cell memory in the H-2d haplotype. J Virol (2002) 1.67
DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. J Virol (1998) 1.49
Subdominant CD8 T-cell epitopes account for protection against cytomegalovirus independent of immunodomination. J Virol (2008) 1.35
Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J Virol (2005) 1.34
The putative natural killer decoy early gene m04 (gp34) of murine cytomegalovirus encodes an antigenic peptide recognized by protective antiviral CD8 T cells. J Virol (2000) 1.18
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). J Virol (2000) 1.16
Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins. Clin Vaccine Immunol (2007) 1.08
Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection by using an attenuated MCMV mutant. J Virol (1998) 1.05
CD8 T-cell-based immunotherapy of cytomegalovirus infection: "proof of concept" provided by the murine model. Med Microbiol Immunol (2008) 1.01
Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. J Virol (2007) 0.98
Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. J Virol (2003) 0.88
25-Hydroxycholesterol activates the integrated stress response to reprogram transcription and translation in macrophages. J Biol Chem (2013) 0.84
Comparison of multiple DNA vaccines for protection against cytomegalovirus infection in BALB/c mice. Virol J (2014) 0.75
Preliminary evidence that the novel host-derived immunostimulant EP67 can act as a mucosal adjuvant. Clin Immunol (2015) 0.75
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The dendritic cell system and its role in immunogenicity. Annu Rev Immunol (1991) 23.09
Direct gene transfer into mouse muscle in vivo. Science (1990) 10.39
Heterologous protection against influenza by injection of DNA encoding a viral protein. Science (1993) 10.14
Cytotoxic t cells in cytomegalovirus infection: HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med (1982) 5.72
Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. Lancet (1991) 5.42
Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J Virol (1985) 4.76
CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J Virol (1987) 4.58
DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci U S A (1993) 4.49
Removal of endotoxin from protein solutions by phase separation using Triton X-114. J Immunol Methods (1990) 3.48
Significance of herpesvirus immediate early gene expression in cellular immunity to cytomegalovirus infection. Nature (1984) 3.26
Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature (1991) 3.03
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. Nature (1989) 2.76
Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci U S A (1994) 2.58
A nonstructural viral protein expressed by a recombinant vaccinia virus protects against lethal cytomegalovirus infection. J Virol (1988) 2.34
Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J Exp Med (1991) 2.27
Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology (1994) 2.04
Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J Virol (1990) 1.99
Molecular basis for cytolytic T-lymphocyte recognition of the murine cytomegalovirus immediate-early protein pp89. J Virol (1988) 1.97
Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol (1995) 1.94
Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA. J Virol (1993) 1.92
Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine (1993) 1.89
Cytotoxic T lymphocyte response to murine cytomegalovirus infection. Nature (1978) 1.89
Protection against mycoplasma infection using expression-library immunization. Nature (1995) 1.88
DNA immunization confers protection against lethal lymphocytic choriomeningitis virus infection. J Virol (1995) 1.83
Cytolytic T lymphocyte recognition of the murine cytomegalovirus nonstructural immediate-early protein pp89 expressed by recombinant vaccinia virus. J Exp Med (1987) 1.57
A nonstructural polypeptide encoded by immediate-early transcription unit 1 of murine cytomegalovirus is recognized by cytolytic T lymphocytes. J Exp Med (1987) 1.52
Host immune response to cytomegalovirus: products of transfected viral immediate-early genes are recognized by cloned cytolytic T lymphocytes. J Virol (1987) 1.47
DNA vaccination against persistent viral infection. J Virol (1995) 1.33
Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology (1991) 1.33
Nucleic acid vaccination primes hepatitis B virus surface antigen-specific cytotoxic T lymphocytes in nonresponder mice. J Virol (1995) 1.25
Complexity of the cytokine and antibody response elicited by immunizing mice with Plasmodium yoelii circumsporozoite protein plasmid DNA. J Immunol (1995) 1.24
Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol (1986) 1.11
Cytomegalovirus infection following marrow transplantation: risk, treatment, and prevention. Birth Defects Orig Artic Ser (1984) 1.06
Animal cytomegaloviruses. Microbiol Rev (1990) 1.02
Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99). Virology (1994) 1.01
DNA immunization against experimental genital herpes simplex virus infection. J Infect Dis (1996) 1.00
Vaccination of mice with herpes simplex virus type 1 glycoprotein D DNA produces low levels of protection against lethal HSV-1 challenge. Antiviral Res (1995) 0.99
Cytomegalovirus and latency: an overview. Virchows Arch B Cell Pathol Incl Mol Pathol (1993) 0.96
Molecular analysis of herpesviral gene products recognized by protective cytolytic T lymphocytes. Immunol Lett (1987) 0.84
Human Ig production and isotype switching in severe combined immunodeficient-human mice. J Immunol (1993) 0.80
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell (1978) 7.46
Transcription in human fibroblasts permissively infected by human cytomegalovirus strain AD169. Virology (1983) 4.58
Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. Proc Natl Acad Sci U S A (1978) 4.47
Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs. J Virol (1975) 3.65
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis (1984) 3.10
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA. Proc Natl Acad Sci U S A (1974) 2.89
Human immunodeficiency virus infection of human-PBL-SCID mice. Science (1991) 2.77
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII. J Virol (1982) 2.59
Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J Virol (1982) 2.52
Characteristics of cellular RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.50
Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol (1998) 2.18
Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol (1985) 2.15
In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol Cell Biol (1993) 2.11
Uninfected avian cells contain RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.10
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain). Virology (1983) 2.06
Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol (1994) 1.94
2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol (1986) 1.91
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Enzymatic amplification of human cytomegalovirus sequences by polymerase chain reaction. J Clin Microbiol (1989) 1.81
Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol (2000) 1.81
Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J Virol (1984) 1.73
Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J Virol (1989) 1.57
p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol (1998) 1.57
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Polyadenylic acid on poliovirus RNA IV. Poly(U) in replicative intermediate and double-stranded RNA. Virology (1975) 1.51
Post-transcriptional control of avian oncornavirus transforming gene sequences in mammalian cells. Nature (1977) 1.48
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169. J Virol (1988) 1.44
Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter. J Virol (1994) 1.44
CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol (1996) 1.43
Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J Virol (1986) 1.42
Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol (1998) 1.41
Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology (1991) 1.33
Transcription in mouse embryo cells permissively infected by murine cytomegalovirus. Virology (1983) 1.30
An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus. J Virol (1992) 1.24
The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor. J Virol (1990) 1.24
Regenerating adult chicken skeletal muscle and satellite cell cultures express embryonic patterns of myosin and tropomyosin isoforms. Dev Biol (1983) 1.21
Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2000) 1.21
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). J Virol (2000) 1.16
Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol (1986) 1.11
Polyadenylic acid on poliovirus RNA. III. In vitro addition of polyadenylic acid to poliovirus RNAs. J Virol (1975) 1.09
Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol (2008) 1.09
Replication of the murine cytomegalovirus genome: structure and role of the termini in the generation and cleavage of concatenates. Virology (1988) 1.08
The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol (1994) 1.08
Studies on the function of polyadenylic acid on poliovirus RNA. Cell (1975) 1.07
Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol (1998) 1.05
Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology (1994) 1.05
The use of DNA probes in studies of human cytomegalovirus. Clin Chem (1985) 1.04
Regulation of human cytomegalovirus gene expression. Adv Virus Res (1999) 1.04
Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99). Virology (1994) 1.01
The oncogenic potential of human cytomegalovirus. Prog Med Virol (1984) 1.01
Human cytomegalovirus (strain AD169) contains sequences related to the avian retrovirus oncogene v-myc. Proc Natl Acad Sci U S A (1983) 0.98
Fusion of the termini of the murine cytomegalovirus genome after infection. J Virol (1984) 0.98
Sequences in human cytomegalovirus which hybridize with the avian retrovirus oncogene v-myc are G + C rich and do not hybridize with the human c-myc gene. Mol Cell Biol (1985) 0.98
Development of dopaminergic neurons in the human substantia nigra. Exp Neurol (1991) 0.96
Cell-related sequences in the DNA genome of human cytomegalovirus strain AD169. J Virol (1985) 0.94
Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol (1991) 0.93
Poly(A) on mengovirus RNA. J Virol (1975) 0.90
Genesis of a virus-transforming gene. Natl Cancer Inst Monogr (1978) 0.89
Use of molecular probes to detect human cytomegalovirus and human immunodeficiency virus. Clin Chem (1989) 0.89
Molecular epidemiology of cytomegalovirus infections in premature twin infants and their mother. Pediatr Infect Dis (1983) 0.87
Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol (1995) 0.85
The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts. Virology (2001) 0.82
Gonyauline: a novel endogenous substance shortening the period of the circadian clock of a unicellular alga. Experientia (1991) 0.79
Molecular analysis of the differential restriction of human immunodeficiency virus type 1 replication in neuronal cell lines. J Gen Virol (1997) 0.78
Streptomycin retards the phenotypic maturation of chick myogenic cells. In Vitro (1984) 0.78
A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol (1997) 0.77
The molecular biology of poliovirus. Sci Am (1975) 0.76
Gene-specific probes for avian retroviruses. Curr Top Microbiol Immunol (1981) 0.75